World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03518463
Date of registration: 16/04/2018
Prospective Registration: No
Primary sponsor: Mbarara University of Science and Technology
Public title: Enhanced Recovery After Surgery for Emergency Caesarean Deliveries ERAS-Mbarara
Scientific title: Enhanced Recovery After Surgery Versus Standard Recovery for Emergency Caesarean Deliveries at Mbarara Hospital, Uganda: A Randomized Control Trial
Date of first enrolment: June 20, 2017
Target sample size: 160
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03518463
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Investigator, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Uganda
Contacts
Name:     Baluku Moris, MD
Address: 
Telephone:
Email:
Affiliation:  Mbarara University of Science and Technology
Key inclusion & exclusion criteria

Inclusion Criteria:

- We included women who were ASA 1 and 2 mothers who were delivering by emergency
caesarean section using spinal anesthetic technique.

Exclusion Criteria:

- Exclusion criteria included refusal to consent, pregnancy complicated by preeclampsia,
antepartum hemorrhage, malaria, gestational diabetes mellitus, physical disability
that would prevent postoperative mobilization and mental illness precluding
comprehension of protocols.



Age minimum: 18 Years
Age maximum: 45 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Pregnancy Related
Intervention(s)
Combination Product: Enhanced recovery after surgery (ERAS)
Primary Outcome(s)
Length of hospital stay [Time Frame: Measured from surgery up to 120 hours.]
Secondary Outcome(s)
Complication rates [Time Frame: Pain was assessed after 6 hours postoperative; PONV, pruritus and urine retention were assessed for 24 hours; headache was assessed for 1 week; wound infection, puerperal sepsis and readmission were assessed up to 30 days postoperative]
Secondary ID(s)
MUST 0606/2018
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history